isocarboxazid has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Normal dosage isocarboxazide may be prescribed for all patients because isocarboxazide is not metabolized through the CYP2D6 enzyme complex like most other antidepressants." | 2.52 | [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression]. ( Brøsen, K; Krogh-Nielsen, L; Larsen, JK, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, JK | 1 |
| Krogh-Nielsen, L | 1 |
| Brøsen, K | 1 |
1 review available for isocarboxazid and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
[The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Diet; Drug Interactions; Edema; Hum | 2015 |